Marker Therapeutics, Inc.

Tagged: acting chief medical officer

TapImmune Appoints Richard Kenney, M.D., F.A.C.P., as Acting Chief Medical Officer

Dr. Kenney will continue to manage the Company’s ongoing and planned clinical programs for its novel, multi-epitope, T-cell vaccine candidates.

Read More